Charles V. Baltic III, Director at MEI Pharma, Inc. (MEIP), bought 81,500 shares at $0.23 ($19K) on 2023-02-28, disclosed to the SEC on 2023-03-01.
Open-market purchase of $19k MEIP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| MEIP | BUY | 2015-01-23 | $19K | — | Filing → |
| MEIP | BUY | 2015-01-02 | $13K | — | Filing → |
| MEIP | BUY | 2014-07-02 | $13K | — | Filing → |